Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,247,454.10
- Aug. 18, 2025
- Blake Borgeson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 31, 2023 | COO | 3,000 | $8.63 | Sell | $25,890.00 | |
May 30, 2023 | Director | 8,885 | $8.79 | Sell | $78,099.15 | |
May 16, 2023 | Director | 8,885 | $5.09 | Sell | $45,224.65 | |
May 3, 2023 | CEO | 33,073 | $4.71 | Sell | $155,773.83 | |
April 18, 2023 | Director | 8,885 | $5.93 | Sell | $52,688.05 | |
April 5, 2023 | CEO | 13,327 | $6.46 | Sell | $86,092.42 | |
April 4, 2023 | Director | 8,885 | $6.53 | Sell | $58,019.05 | |
March 21, 2023 | Director | 8,885 | $7.40 | Sell | $65,749.00 | |
March 8, 2023 | CEO | 70,890 | $8.10 | Sell | $574,209.00 | |
March 7, 2023 | Director | 8,885 | $8.33 | Sell | $74,012.05 | |
March 2, 2023 | CEO | 18,500 | $7.92 | Sell | $146,520.00 | |
Feb. 27, 2023 | Major Shareholder | 52,500 | $7.69 | Buy | $403,725.00 | |
Feb. 23, 2023 | COO | 8,000 | $7.82 | Sell | $62,560.00 | |
Feb. 23, 2023 | Major Shareholder | 51,864 | $7.79 | Buy | $404,020.56 | |
Feb. 21, 2023 | Major Shareholder | 94,418 | $7.74 | Buy | $730,795.32 | |
Feb. 21, 2023 | Director | 8,885 | $7.73 | Sell | $68,681.05 | |
Feb. 16, 2023 | Major Shareholder | 42,682 | $7.90 | Buy | $337,187.80 | |
Feb. 15, 2023 | Insider | 7,486 | $8.33 | Sell | $62,358.38 | |
Feb. 14, 2023 | Major Shareholder | 6,300 | $7.95 | Buy | $50,085.00 | |
Feb. 10, 2023 | Major Shareholder | 11,000 | $7.98 | Buy | $87,780.00 | |
Feb. 7, 2023 | Director | 8,885 | $8.81 | Sell | $78,276.85 | |
Jan. 26, 2023 | COO | 8,000 | $8.07 | Sell | $64,560.00 | |
Jan. 25, 2023 | Major Shareholder | 24,526 | $7.88 | Buy | $193,264.88 | |
Jan. 24, 2023 | Director | 8,885 | $8.71 | Sell | $77,388.35 | |
Jan. 17, 2023 | Insider | 10,000 | $9.16 | Sell | $91,600.00 | |
Jan. 10, 2023 | Director | 8,885 | $7.69 | Sell | $68,325.65 | |
Jan. 9, 2023 | Major Shareholder | 76,046 | $7.64 | Buy | $580,991.44 | |
Jan. 5, 2023 | CEO | 18,500 | $7.39 | Sell | $136,715.00 | |
Dec. 29, 2022 | COO | 8,000 | $7.70 | Sell | $61,600.00 | |
Dec. 27, 2022 | Director | 8,885 | $7.25 | Sell | $64,416.25 | |
Dec. 15, 2022 | Insider | 10,000 | $8.85 | Sell | $88,500.00 | |
Dec. 13, 2022 | Director | 8,885 | $8.96 | Sell | $79,609.60 | |
Dec. 1, 2022 | CEO | 37,210 | $9.02 | Sell | $335,634.20 | |
Nov. 29, 2022 | Director | 8,885 | $8.75 | Sell | $77,743.75 | |
Nov. 17, 2022 | COO | 16,000 | $10.96 | Sell | $175,360.00 | |
Nov. 16, 2022 | Director | 17,770 | $11.12 | Sell | $197,602.40 | |
Nov. 15, 2022 | Insider | 10,000 | $12.31 | Sell | $123,100.00 | |
Nov. 3, 2022 | CEO | 36,693 | $10.00 | Sell | $366,930.00 | |
Oct. 27, 2022 | COO | 16,000 | $10.72 | Sell | $171,520.00 | |
Oct. 14, 2022 | Insider | 10,000 | $10.92 | Sell | $109,200.00 | |
Oct. 6, 2022 | CEO | 36,053 | $11.58 | Sell | $417,493.74 | |
Sept. 29, 2022 | COO | 16,000 | $10.86 | Sell | $173,760.00 | |
Sept. 15, 2022 | Insider | 10,000 | $13.36 | Sell | $133,600.00 | |
Aug. 16, 2022 | COO | 16,000 | $12.60 | Sell | $201,600.00 | |
Aug. 16, 2022 | Insider | 30,000 | $12.61 | Sell | $378,300.00 | |
Aug. 4, 2022 | CEO | 36,825 | $9.49 | Sell | $349,469.25 | |
July 7, 2022 | CEO | 37,114 | $9.05 | Sell | $335,881.70 | |
July 7, 2022 | Chief Executive Officer | 18,500 | $0.00 | Buy | $0.00 | |
July 7, 2022 | Chief Executive Officer | 18,614 | $9.04 | Sell | $168,270.56 | |
June 2, 2022 | CEO | 39,690 | $6.09 | Sell | $241,712.10 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Zavain Dar, Najat Khan, and Terry-Ann Burrell
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Aug. 18, 2025.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.